|
TBC1D23 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.818020E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.432000E-02 |
| Normal-vs-Stage2 |
2.623000E-01 |
| Normal-vs-Stage3 |
9.993800E-02 |
| Normal-vs-Stage4 |
3.930800E-01 |
| Stage1-vs-Stage2 |
7.035800E-01 |
| Stage1-vs-Stage3 |
9.868200E-01 |
| Stage1-vs-Stage4 |
3.052000E-01 |
| Stage2-vs-Stage3 |
7.980600E-01 |
| Stage2-vs-Stage4 |
6.979200E-01 |
| Stage3-vs-Stage4 |
4.576600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.089800E-02 |
| Normal-vs-AfricanAmerican |
2.568500E-04 |
| Normal-vs-Asian |
7.937800E-01 |
| Caucasian-vs-AfricanAmerican |
1.705880E-02 |
| Caucasian-vs-Asian |
2.155400E-01 |
| AfricanAmerican-vs-Asian |
4.568100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.003500E-03 |
| Normal-vs-Female |
2.464600E-01 |
| Male-vs-Female |
1.597160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.586600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.792030E-01 |
| Normal-vs-Age(61-80Yrs) |
1.281650E-02 |
| Normal-vs-Age(81-100Yrs) |
1.815230E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.597400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.568200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.781700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.193000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.402900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.280000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.993800E-01 |
| Normal-vs-Grade 2 |
2.420600E-01 |
| Normal-vs-Grade 3 |
2.343000E-03 |
| Normal-vs-Grade 4 |
5.453800E-02 |
| Grade 1-vs-Grade 2 |
4.604400E-01 |
| Grade 1-vs-Grade 3 |
1.624760E-01 |
| Grade 1-vs-Grade 4 |
1.501750E-01 |
| Grade 2-vs-Grade 3 |
1.211950E-01 |
| Grade 2-vs-Grade 4 |
3.518200E-01 |
| Grade 3-vs-Grade 4 |
8.879600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.135800E-01 |
| Normal-vs-ccB subtype |
1.016960E-01 |
| ccA subtype-vs-ccB subtype |
4.484400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.323550E-01 |
| Normal-vs-N1 |
8.785800E-01 |
| N0-vs-N1 |
4.887800E-01 |
|
|
